Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease

Liver International

Volumn 35, Issue 12, 2015, Pages 2514-2521

  Mueller, Sebastian ^a,b   Englert, Stefan ^b   Seitz, Helmut K ^a,b   Badea, Radu I ^c   Erhardt, Andreas ^d   Bozaari, Bita ^e   Beaugrand, Michel ^f   Lupşor Platon, Monica ^c  

^a Krankenhaus Salem   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d Petrus Krankenhaus   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITÉ PARIS 13   (France)

Author keywords

Alcoholic liver disease; Fibrosis; Hepatitis C; Inflammation; Liver stiffness

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; INFLAMMATION; LIVER FIBROSIS; LIVER LOBULE; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PORTAL VEIN; REFERENCE VALUE; THROMBOCYTE COUNT; BIOPSY; COMPLICATION; DISEASE COURSE; ELASTOGRAPHY; HEPATITIS C, CHRONIC; LIVER; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT ACUITY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY;

ADULT; ASPARTATE AMINOTRANSFERASES; BIOPSY; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; PATIENT ACUITY; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 84954545504     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12904     Document Type: Article

References (42)

1. Kumar S, Jacobson IM. Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C. J Hepatol 2014; 61(1 Suppl.): S91-7.
2. Baumert TF, Zeuzem S. Overcoming the roadblocks in hepatitis C virus infection. J Hepatol 2014; 61(1 Suppl.): S1-2.
3. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
4. Ganne-Carrie N, Ziol M, De Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-7.
5. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
6. Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med 2010; 2: 49-67.
7. Castera LPM. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010; 59: 861-6.
8. Mueller S, Millonig G, Sarovska L, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010; 16: 966-72.
9. Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20: 14626-41.
10. Vignier N, Esmat G, Sharkawy AE, et al. Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt. J Viral Hepat 2011; 18: e358-65.
11. Boursier J, Konate A, Gorea G, et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol 2008; 6: 1263-9.
12. Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-2.
13. Wong GL, Wong VW, Choi PC, et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther 2011; 16: 165-72.
14. European Association for the Study of the Liver. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015; 63: 237-64.
15. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-5.
16. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-4.
17. Dechene A, Sowa JP, Gieseler RK, et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 2010; 52: 1008-16.
18. Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-10.
19. Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48: 1718-23.
20. Mederacke I, Wursthorn K, Kirschner J, et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009; 29: 1500-6.
21. Hines CD, Lindstrom MJ, Varma AK, Reeder SB. Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging 2011; 33: 239-44.
22. Arena U, Lupsor Platon M, Stasi C, et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 2013; 58: 65-72.
23. Lanzi A, Gianstefani A, Mirarchi MG, et al. Liver Al amyloidosis as a possible cause of high liver stiffness values. Eur J Gastroenterol Hepatol 2010; 22: 895-7.
24. Bastard C, Bosisio MR, Chabert M, et al. Transient micro-elastography: a novel non-invasive approach to measure liver stiffness in mice. World J Gastroenterol 2011; 17: 968-75.
25. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-9.
26. Oliveri F, Coco B, Ciccorossi P, et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 2008; 14: 6154-62.
27. Fung J, Lai CL, Cheng C, et al. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 2011; 106: 492-6.
28. Liang XE, Chen YP, Zhang Q, et al. Dynamic evaluation of liver stiffness measurement to improve diagnostic accuracy of liver cirrhosis in patients with chronic hepatitis B acute exacerbation. J Viral Hepat 2011; 18: 884-91.
29. Nahon P, Kettaneh A, Tengher-Barna I, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49: 1062-8.
30. Nguyen-Khac E, Chatelain D, Tramier B, et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008; 28: 1188-98.
31. Kim SG, Kim YS, Jung SW, et al. [The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease]. Korean J Hepatol 2009; 15: 42-51.
32. Trabut J B, Thepot V, Nalpas B, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res 2012; 36: 1407-11.
33. Gelsi E, Dainese R, Truchi R, et al. Effect of detoxification on liver stiffness assessed by fibroscan((R)) in alcoholic patients. Alcohol Clin Exp Res 2011; 35: 566-70.
34. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
35. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
36. Fleiss JL, Cohen J. The equivalence of weighted Kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973; 33: 613-9.
37. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-64.
38. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85.
39. European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57: 399-420.
40. Fung J, Lai CL, But D, et al. Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. Hepatol Int 2011; 4: 716-22.
41. Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L, Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 2011; 43: 887-92.
42. Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-24.